Development of grade @ + rash on cetuximab was associated with a trend towards increased OS ( HR @ with @ % CI @-@ @ and p = @ ) and PFS ( HR @ with @ % CI @-@ @ and p = @ ) as compared to grade @/@ rash in patients with WT tumours .